nivolumab
bms
['kudos', 'prosper,data']
kudos to #drnaomihaas &amp; for #prosper at #esmo22 - a herculean effort at assessing neoadjuvant tx. as ever, offers a brilliant discussion of the data, highlighting complexities of the design. (7/10) 
@cityofhope & @cityofhopeoc prof w focus on #kidneycancer, #prostatecancer, #bladdercancer & 90s rock. RTs not endorsements. COI: https://t.co/L7ihnCjLz5